These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11354395)

  • 21. Therapeutic strategy in Paget's disease of bone.
    Meunier PJ; Vignot E
    Bone; 1995 Nov; 17(5 Suppl):489S-491S. PubMed ID: 8573424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
    Major PP; Lipton A; Berenson J; Hortobagyi G
    Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of resistant Paget's disease of bone with pamidronate.
    Mallette LE
    Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological and radiological responses to oral etidronate and tiludronate in Paget's disease of bone.
    Devogelaer JP; Malghem J; Stasse P; Nagant de Deuxchaisnes C
    Bone; 1997 Mar; 20(3):259-61. PubMed ID: 9071477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates: preclinical aspects and use in osteoporosis.
    Fleisch HA
    Ann Med; 1997 Feb; 29(1):55-62. PubMed ID: 9073324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From bathtub ring to osteoporosis: a clinical review of the bisphosphonates.
    Licata AA
    Cleve Clin J Med; 1993; 60(4):284-90. PubMed ID: 8339454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New bisphosphonates in the treatment of bone diseases.
    Gatti D; Adami S
    Drugs Aging; 1999 Oct; 15(4):285-96. PubMed ID: 10582775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates in the management of Paget's disease.
    Ralston SH
    Bone; 2020 Sep; 138():115465. PubMed ID: 32512166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of osteoporosis with bisphosphonates.
    Watts NB
    Rheum Dis Clin North Am; 2001 Feb; 27(1):197-214. PubMed ID: 11285996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of risedronate in Paget's disease.
    Miller PD
    Bone; 1999 May; 24(5 Suppl):91S-92S. PubMed ID: 10321937
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate).
    Fraser TR; Ibbertson HK; Holdaway IM; Rutland M; King A; Dodd G; Wattie DJ
    Aust N Z J Med; 1984 Dec; 14(6):811-8. PubMed ID: 6442563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction and assessment of the response of Paget's disease to bisphosphonate treatment.
    Hosking DJ
    Bone; 1999 May; 24(5 Suppl):69S-71S. PubMed ID: 10321933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone.
    Whitson HE; Lobaugh B; Lyles KW
    Bone; 2006 Oct; 39(4):954-8. PubMed ID: 16769264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of Paget's disease of bone.
    Langston AL; Ralston SH
    Rheumatology (Oxford); 2004 Aug; 43(8):955-9. PubMed ID: 15187244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Midterm outcome of risedronate therapy for patients with Paget's disease of bone in the central part of Japan.
    Nishida Y; Yamada Y; Tsukushi S; Sugiura H; Urakawa H; Ishiguro N
    Clin Rheumatol; 2013 Feb; 32(2):241-5. PubMed ID: 23138882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Paget's disease of bone with alendronate.
    Lombardi A
    Bone; 1999 May; 24(5 Suppl):59S-61S. PubMed ID: 10321931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.
    Dunn CJ; Goa KL
    Drugs; 2001; 61(5):685-712. PubMed ID: 11368289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.